Ribavirin-Free Regimen With Sofosbuvir and Velpatasvir Is Associated With High Efficacy and Improvement of Patient-Reported Outcomes in Patients With Genotypes 2 and 3 Chronic Hepatitis C: Results From Astral-2 and-3 Clinical Trials
Volume
63
Pagination
1042 - 1048
DOI
10.1093/cid/ciw496
Journal
CLINICAL INFECTIOUS DISEASES
Issue
ISSN
1058-4838
Metadata
Show full item recordAuthors
Younossi, ZM; Stepanova, M; Sulkowski, M; Foster, GR; Reau, N; Mangia, A; Patel, K; Brau, N; Roberts, SK; Afdhal, NCollections
- Centre for Immunobiology [1017]